# KRYS (Krystal Biotech, Inc.) - SEC EDGAR Financial Statements

> Krystal Biotech, Inc. reported $470.0M in revenue and net income of $225.2M for the trailing twelve months ended September 30, 2026 (up 30.2% year over year), with a 48.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/KRYS
- Markdown: https://convexityos.com/fundamentals/KRYS.md
- SEC CIK: 0001711279
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001711279&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $470.0M | +30.2% YoY |
| Operating Income | TTM | $227.5M | 48.4% margin |
| Net Income | TTM | $225.2M | 47.9% net margin |
| Diluted EPS | TTM | $7.30 | Split-adjusted |
| Free Cash Flow | TTM | $310.1M | 66.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $911.9M | Total debt: $8.59M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $389.1M | $290.5M | $50.70M | $0 | $0 | -- | -- | -- | -- | -- |
| Research & Development | $58.05M | $53.58M | $46.43M | $42.46M | $27.88M | $17.94M | $15.62M | $7.76M | $3.21M | $741K |
| Selling, General & Admin | $146.7M | $113.6M | $98.29M | $77.73M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $227.8M | $224.8M | $160.3M | $145.2M | $68.28M | $33.00M | $22.08M | $11.92M | $4.77M | $1.14M |
| **Operating Income** | $161.3M | $65.75M | -$109.6M | -$145.2M | -$68.28M | -$33.00M | -$22.08M | -$11.92M | -$4.77M | -$1.14M |
| **EBITDA** | $167.0M | $71.72M | -$105.9M | -$141.1M | -$65.51M | -$31.15M | -$20.99M | -$11.78M | -$4.75M | -$1.14M |
| Interest Expense | -- | -- | $0 | $0 | $1.49M | $0 | -- | -- | -- | -- |
| Income Before Tax | $189.5M | $95.36M | $12.90M | -$140.0M | -$69.57M | -- | -- | -- | -- | -- |
| Income Tax Expense | -$15.36M | $6.20M | $1.97M | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | $204.8M | $89.16M | $10.93M | -$140.0M | -$69.57M | -$32.17M | -$19.09M | -$10.89M | -$7.92M | -$1.15M |
| Basic EPS | $7.08 | $3.12 | $0.40 | -$5.49 | -$3.13 | -$1.71 | -$1.20 | -$0.97 | -$1.48 | -$1.31 |
| **Diluted EPS** | $6.84 | $3.00 | $0.39 | -$5.49 | -$3.13 | -$1.71 | -$1.20 | -$0.97 | -$1.48 | -$1.31 |
| Basic Shares Outstanding | 28.9M | 28.6M | 27.2M | 25.5M | 22.2M | 18.8M | 15.9M | 11.2M | 5.4M | 877.5K |
| Diluted Shares Outstanding | 30.0M | 29.7M | 27.8M | 25.5M | 22.2M | 18.8M | 15.9M | 11.2M | 5.4M | 877.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $127.3M | $119.2M | $116.4M | $107.1M | $97.80M | $96.04M | $88.18M | $91.14M |
| Research & Development | $14.89M | $14.52M | $15.33M | $14.79M | $14.59M | $14.41M | $14.26M | $13.53M |
| Selling, General & Admin | $33.75M | $39.85M | $41.01M | $41.45M | $37.58M | $35.07M | $32.65M | $31.29M |
| Total Operating Expenses | $56.20M | $60.80M | $62.67M | $62.84M | $56.43M | $56.64M | $51.93M | $49.76M |
| **Operating Income** | $71.14M | $58.42M | $53.69M | $44.27M | $41.37M | $39.40M | $36.25M | $41.38M |
| **EBITDA** | $72.64M | $59.82M | $55.21M | $45.83M | $42.77M | $40.70M | $37.66M | $42.74M |
| Income Before Tax | $80.14M | $66.08M | $61.44M | $51.13M | $47.97M | $46.77M | $43.60M | $48.61M |
| Income Tax Expense | $17.08M | $11.31M | $5.51M | -$269K | -$31.40M | $8.44M | $7.86M | $3.13M |
| **Net Income** | $63.07M | $54.77M | $55.93M | $51.40M | $79.36M | $38.33M | $35.73M | $45.48M |
| Basic EPS | $2.13 | $1.85 | $1.91 | -- | $2.74 | $1.33 | $1.24 | -- |
| **Diluted EPS** | $2.05 | $1.79 | $1.83 | -- | $2.66 | $1.29 | $1.20 | -- |
| Basic Shares Outstanding | 29.6M | 29.5M | 29.3M | -- | 29.0M | 28.9M | 28.8M | -- |
| Diluted Shares Outstanding | 30.8M | 30.7M | 30.5M | -- | 29.8M | 29.7M | 29.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $496.3M | $344.9M | $358.3M | $161.9M | $341.2M | $268.3M | $187.5M | $103.7M | $49.59M | $1.92M |
| Short-Term Investments | $331.5M | $252.7M | $173.8M | $217.3M | $96.85M | $2.99M | $6.17M | $8.09M | -- | -- |
| **Cash & Short-Term Investments** | $827.8M | $597.5M | $532.2M | $379.2M | $438.1M | $271.3M | $193.7M | $111.8M | $49.59M | $1.92M |
| Accounts Receivable, Net | $127.4M | $104.7M | $42.04M | $0 | -- | -- | -- | -- | -- | -- |
| Inventory | $40.48M | $26.51M | $6.99M | $0 | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | $19K | -- |
| **Total Current Assets** | $1.02B | $742.0M | $587.9M | $383.8M | $442.3M | $275.1M | $195.9M | $112.7M | $49.91M | $2.17M |
| Property, Plant & Equipment, Net | $150.8M | $155.2M | $161.2M | $161.7M | $112.4M | $30.88M | $8.47M | $3.01M | $200K | $13K |
| Long-Term Investments | $128.1M | $152.1M | $61.95M | $4.62M | $64.37M | $0 | $497K | -- | -- | -- |
| Other Non-Current Assets | $287K | $231K | $263K | $324K | $74K | $1.61M | $1.46M | $452K | -- | -- |
| **Total Non-Current Assets** | $309.2M | $313.8M | $230.4M | $174.7M | $184.0M | $35.79M | $13.14M | $3.47M | $200K | $13K |
| **Total Assets** | $1.33B | $1.06B | $818.4M | $558.5M | $626.3M | $310.8M | $209.0M | $116.1M | $50.11M | $2.18M |
| Accounts Payable | $3.24M | $4.99M | $4.13M | $3.98M | $8.40M | $2.10M | $1.02M | $888K | $193K | $42K |
| Other Current Liabilities | $3.58M | $2.40M | $2.20M | $267K | $87K | $26K | $12K | $39K | -- | -- |
| **Total Current Liabilities** | $102.9M | $102.0M | $33.09M | $28.85M | $25.74M | $15.45M | $3.33M | $2.60M | $640K | $43K |
| Other Non-Current Liabilities | $3.72M | $1.42M | $0 | -- | -- | -- | -- | $294K | -- | -- |
| **Total Non-Current Liabilities** | $11.29M | $7.46M | $6.62M | $7.37M | $6.98M | $3.31M | $2.78M | $294K | $0 | $1.85M |
| **Total Liabilities** | $114.2M | $109.5M | $39.71M | $36.22M | $32.72M | $18.76M | $6.11M | $2.89M | $640K | $1.89M |
| **Total Debt (incl. Leases)** | $9.34M | $7.26M | $8.09M | $8.93M | $8.02M | $3.95M | $3.26M | -- | -- | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | $24.16M | -$180.7M | -$269.8M | -$280.8M | -$140.8M | -$71.21M | -$39.05M | -$19.96M | -$9.07M | -$1.15M |
| Accumulated Other Comp. Income | $1.14M | -$190K | $638K | -$728K | -$163K | $6.0K | $10K | $2.0K | -- | -- |
| **Total Stockholders' Equity** | $1.22B | $946.4M | $778.6M | $522.2M | $593.6M | $292.1M | $202.9M | $113.2M | $49.47M | $289K |
| Total Equity | $1.22B | $946.4M | $778.6M | $522.2M | $593.6M | $292.1M | $202.9M | $113.2M | $49.47M | $289K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $462.8M | $427.7M | $501.3M | $496.3M | $392.6M | $353.8M | $308.8M | $344.9M |
| Short-Term Investments | $449.0M | $417.9M | $322.1M | $331.5M | $338.5M | $328.2M | $308.1M | $252.7M |
| **Cash & Short-Term Investments** | $911.9M | $845.6M | $823.4M | $827.8M | $731.1M | $682.0M | $616.8M | $597.5M |
| Accounts Receivable, Net | $133.1M | $138.7M | $127.0M | $127.4M | $129.6M | $111.4M | $103.3M | $104.7M |
| Inventory | $50.79M | $45.56M | $42.65M | $40.48M | $37.63M | $31.04M | $29.94M | $26.51M |
| **Total Current Assets** | $1.12B | $1.06B | $1.02B | $1.02B | $925.6M | $841.3M | $766.8M | $742.0M |
| Property, Plant & Equipment, Net | $152.3M | $153.8M | $153.6M | $150.8M | $148.9M | $150.4M | $151.1M | $155.2M |
| Long-Term Investments | $282.3M | $257.3M | $193.5M | $128.1M | $133.1M | $138.8M | $148.5M | $152.1M |
| Other Non-Current Assets | $269K | $284K | $300K | $287K | $333K | $197K | $218K | $231K |
| **Total Non-Current Assets** | $464.3M | $441.0M | $377.2M | $309.2M | $314.4M | $297.0M | $307.6M | $313.8M |
| **Total Assets** | $1.59B | $1.50B | $1.40B | $1.33B | $1.24B | $1.14B | $1.07B | $1.06B |
| Accounts Payable | $6.73M | $6.54M | $4.09M | $3.24M | $2.10M | $7.12M | $2.67M | $4.99M |
| Other Current Liabilities | $4.33M | $3.43M | $3.18M | $3.58M | $3.28M | $2.17M | $3.39M | $2.40M |
| **Total Current Liabilities** | $142.1M | $127.4M | $107.8M | $102.9M | $91.27M | $86.90M | $79.49M | $102.0M |
| Other Non-Current Liabilities | $1.56M | $7.08M | $5.12M | $3.72M | $3.14M | $2.79M | $1.95M | $1.42M |
| **Total Non-Current Liabilities** | $8.33M | $14.12M | $12.44M | $11.29M | $10.95M | $10.85M | $10.25M | $7.46M |
| **Total Liabilities** | $150.5M | $141.5M | $120.2M | $114.2M | $102.2M | $97.75M | $89.74M | $109.5M |
| **Total Debt (incl. Leases)** | $8.59M | $8.85M | $9.11M | $9.34M | $9.51M | $9.68M | $9.66M | $7.26M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | $197.9M | $134.9M | $80.09M | $24.16M | -$27.24M | -$106.6M | -$144.9M | -$180.7M |
| Accumulated Other Comp. Income | -$9.24M | -$4.33M | -$1.62M | $1.14M | $1.10M | $1.16M | $390K | -$190K |
| **Total Stockholders' Equity** | $1.44B | $1.36B | $1.28B | $1.22B | $1.14B | $1.04B | $984.7M | $946.4M |
| Total Equity | $1.44B | $1.36B | $1.28B | $1.22B | $1.14B | $1.04B | $984.7M | $946.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $204.8M | $89.16M | $10.93M | -$140.0M | -$69.57M | -$32.17M | -$19.09M | -$10.89M | -$7.92M | -$1.15M |
| Depreciation & Amortization | $5.72M | $5.97M | $3.73M | $4.05M | $2.77M | $1.85M | $1.09M | $141K | $23K | $2.0K |
| Stock-Based Compensation | $54.51M | $49.13M | $39.93M | $33.23M | $15.32M | $3.27M | $1.24M | $792K | $246K | $33K |
| Change in Receivables | -$22.12M | -$62.71M | -$42.04M | $0 | $0 | -- | -- | -- | -- | -- |
| Change in Inventory | -$6.29M | -$11.91M | -$4.47M | $0 | $0 | -- | -- | -- | -- | -- |
| Change in Payables | $826K | $1.01M | -$101K | -$1.25M | $712K | $783K | -$199K | $112K | $133K | $42K |
| **Operating Cash Flow** | $200.9M | $123.4M | -$88.80M | -$100.6M | -$47.94M | -$26.08M | -$18.69M | -$9.45M | -$3.89M | -$1.31M |
| Capital Expenditure | -$11.95M | -$4.24M | -$11.80M | -$52.98M | -$68.34M | -$14.84M | -$6.40M | -$2.23M | -$210K | -$15K |
| **Free Cash Flow** | $188.9M | $119.2M | -$100.6M | -$153.5M | -$116.3M | -$40.93M | -$25.09M | -$11.68M | -$4.10M | -$1.33M |
| Purchases of Investments | -$422.5M | -$457.7M | -$508.8M | -$318.8M | -$190.5M | -$3.21M | -$8.60M | -$8.09M | -- | -- |
| **Investing Cash Flow** | -$58.42M | -$163.4M | $82.64M | -$114.1M | -$226.8M | -$11.18M | -$4.99M | -$10.32M | -$210K | -$15K |
| Common Stock Issued | $0 | $0 | $159.7M | $28.99M | $355.6M | $118.0M | $107.5M | $73.85M | $42.47M | $100K |
| **Financing Cash Flow** | $8.71M | $27.01M | $202.8M | $35.35M | $347.7M | $118.0M | $107.5M | $73.85M | $51.77M | $3.25M |
| **Net Change in Cash** | $151.4M | -$13.46M | $196.4M | -$179.3M | $72.98M | $80.75M | $83.84M | $54.08M | $47.67M | $1.92M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $63.07M | $54.77M | $55.93M | $51.40M | $79.36M | $38.33M | $35.73M | $45.48M |
| Depreciation & Amortization | $1.50M | $1.40M | $1.52M | $1.56M | $1.40M | $1.30M | $1.41M | $1.36M |
| Stock-Based Compensation | $13.94M | $14.16M | $13.61M | $13.76M | $13.15M | $14.12M | $13.48M | $13.36M |
| Change in Receivables | $5.43M | -$11.97M | $58K | $2.49M | -$17.92M | -$8.18M | $1.49M | -$7.45M |
| Change in Inventory | -$2.00M | -$958K | -$243K | -$1.06M | -$4.71M | $880K | -$1.40M | -$6.52M |
| Change in Payables | $215K | $3.06M | $1.02M | -$183K | -$4.02M | $4.12M | $906K | -$591K |
| **Operating Cash Flow** | $91.25M | $74.79M | $80.38M | $77.51M | $39.66M | $52.73M | $30.97M | $52.84M |
| Capital Expenditure | -$996K | -$3.56M | -$7.15M | -$2.14M | -$1.70M | -$1.90M | -$6.20M | -$801K |
| **Free Cash Flow** | $90.25M | $71.22M | $73.23M | $75.37M | $37.95M | $50.83M | $24.77M | $52.04M |
| Purchases of Investments | -$194.0M | -$258.0M | -$160.0M | -$72.46M | -$98.37M | -$113.9M | -$137.8M | -$143.5M |
| **Investing Cash Flow** | -$57.98M | -$161.6M | -$63.58M | $11.16M | -$4.29M | -$10.53M | -$54.77M | -$83.78M |
| **Financing Cash Flow** | $3.41M | $15.05M | -$10.46M | $15.67M | $3.71M | $1.80M | -$12.47M | $2.43M |
| **Net Change in Cash** | $35.10M | -$73.57M | $5.01M | $103.7M | $38.77M | $45.06M | -$36.09M | -$29.10M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 41.5% | 22.6% | -216.2% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | 52.6% | 30.7% | 21.6% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | 16.8% | 9.4% | 1.4% | -26.8% | -11.7% | -11.0% | -9.4% | -9.6% | -16.0% | -397.9% |
| Return on Assets (ROA) | 15.4% | 8.4% | 1.3% | -25.1% | -11.1% | -10.3% | -9.1% | -9.4% | -15.8% | -52.7% |
| Current Ratio | 9.95x | 7.28x | 17.76x | 13.30x | 17.18x | 17.80x | 58.88x | 43.39x | 77.99x | 50.44x |
| Quick Ratio | 9.56x | 7.02x | 17.55x | 13.30x | 17.02x | 17.56x | 58.22x | 43.05x | 77.49x | 44.72x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | +33.9% | +473.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | +145.3% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | +129.7% | +715.6% | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | +126.9% | +680.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +62.7% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | +58.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 48.4% | 44.9% | 42.8% | 41.5% | 42.4% | 38.8% | 32.6% | 22.6% |
| **Net Profit Margin** | 47.9% | 54.8% | 53.9% | 52.6% | 53.3% | 40.8% | 37.2% | 30.7% |
| Return on Equity (ROE) | 15.7% | 17.8% | 17.6% | 16.8% | 17.5% | 14.1% | 12.6% | 9.4% |
| Return on Assets (ROA) | 14.2% | 16.1% | 16.1% | 15.4% | 16.0% | 12.9% | 11.5% | 8.4% |
| Current Ratio | 7.89x | 8.32x | 9.46x | 9.95x | 10.14x | 9.68x | 9.65x | 7.28x |
| Quick Ratio | 7.53x | 7.96x | 9.06x | 9.56x | 9.73x | 9.33x | 9.27x | 7.02x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | +30.2% | +24.1% | +31.9% | +17.5% | +16.6% | +36.6% | +94.9% | +116.3% |
| Operating Income Growth (YoY) | +72.0% | +48.3% | +48.1% | +7.0% | +84.1% | +359.9% | -- | +1173.9% |
| **Net Income Growth (YoY)** | -20.5% | +42.9% | +56.5% | +13.0% | +192.0% | +146.2% | +3734.0% | +423.2% |
| EPS Growth (YoY) | -22.3% | +39.1% | +54.0% | -- | +188.4% | +146.3% | +4033.3% | -- |
| Operating Cash Flow Growth (YoY) | +130.1% | +41.8% | +159.6% | +46.7% | -32.6% | -- | +94.9% | -- |
| Free Cash Flow Growth (YoY) | +137.8% | +40.1% | +195.7% | +44.8% | -34.3% | -- | +69.3% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
